Botanical species · safety record

Alpinia hainanensis

The EFSA Compendium of Botanicals holds 12 constituent measurements for Alpinia hainanensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Alpinia hainanensis K.Schum.

12Constituent measurements

0Safety records

5Cited sources

41Licensed products (Canada)

Also recorded as

Alpinia katsumadae Hayata

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 41 licensed products naming Alpinia hainanensis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

New material
Seed
Seed(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cinnamaldehyde	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Labdane diterpenes	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Niacin	Seed	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
(-)-camphor	Aerial part of plants	Essential oil	≥ 0.7 Percent	GC-MS	No resolvable identifier
(-)-camphor	Aerial part of plants	Essential oil	≤ 1.5 Percent	GC-MS	No resolvable identifier
1,8-cineole	Roots and other underground parts	Solvent extraction	45.1 Percent	GC-MS	No resolvable identifier
1,8-cineole	Live plants	Essential oil	≤ 14.4 Percent	GC-MS	No resolvable identifier
1,8-cineole	Live plants	Essential oil	≥ 13.4 Percent	GC-MS	No resolvable identifier
Fenchone	Live plants	Essential oil	≤ 25.1 Percent	GC-MS	No resolvable identifier
Fenchone	Live plants	Essential oil	≥ 0.4 Percent	GC-MS	No resolvable identifier
Myrcene	Live plants	Essential oil	≤ 5.7 Percent	GC-MS	No resolvable identifier
Myrcene	Live plants	Essential oil	≥ 3.3 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Nguyen, Xuan Dung., Dao, Lan Phuong., Leclercq, Piet A. Constituents of the stem, leaf and seed oils of Alpinia katsumadai Hayata L. from Vietnam.. Journal of Essential Oil Research, 1990, vol. 2, no. 5, p. 259-61.
Li, Yuan-Yuan., Chou, Gui-Xin., Wang, Zheng-Tao. Chemical constituents in n-butanol extract from the seeds of Alpinia katsumadai.. Zhongguo Tianran Yaowu, 2009, vol. 7, no. 6, p. 417-420. DOI
Ngo, Koon-Sin., Brown, Geoffrey D. Stilbenes, monoterpenes, diarylheptanoids, labdanes and chalcones from Alpinia katsumadai.. Phytochemistry, 1998, vol. 47, no. 6, p. 1117-1123. DOI
Kuroyanagi, Masanori., Noro, Tadataka., Fukushima, Seigo., Aiyama, Ritsuo., Ikuta, Akira., Itokawa, Hideji., Morita, Makoto. Studies on the constituents of the seeds of Alpinia katsumadai Hayata.. Chemical & Pharmaceutical Bulletin, 1983, vol. 31, no. 5, p. 1544-50. DOI
Phan, Giang M., Phan, Son T., Koenig, Wilfried A. Chemical composition of the essential oil from the rhizomes of Alpinia henryi K. Schum. of Vietnam.. Journal of essential oil research, 2007, vol. 19, no. 6, p. 507-508.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature